Cannabis extract trial offers new hope for controlling severe epilepsy
Disease control
Recruiting now
This study is testing whether a full-spectrum cannabis extract called YCJ-01 can safely reduce the number of seizures in people with Tuberous Sclerosis Complex (TSC) whose epilepsy is not controlled by standard treatments. It is a Phase 3 trial enrolling 84 participants, aged 2 t…
Phase: PHASE3 • Sponsor: Oils4Cure • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC